See also this year's filing and all EDGAR filings for this company.
PDF Report 0001436304_2014_Kythera_Biopharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Keryx Biopharmaceuticals INC', 'shared_tokens': {'biopharmaceuticals'}}, {'other_company': 'Epirus Biopharmaceuticals Inc', 'shared_tokens': {'biopharmaceuticals'}}]} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001436304, Kythera Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 173,276,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 94,000 |
| 3 | remainder_Assets | 37,000 |
| 4 | LiabilitiesCurrent | 17,581,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 5,987,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 16,092,000 |
| 9 | ResearchAndDevelopmentExpense | 33,974,000 |
| 10 | remainder_Expenses | 1,980,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 135,000 |
| 13 | remainder_ComprehensiveNetIncome | 4,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 173,407,000 |
| 1 | Liabilities | 23,568,000 |
| 2 | Expenses | 52,046,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 149,839,000 |
| 5 | NetIncome | -51,911,000 |
| 6 | ComprehensiveNetIncome | -51,909,000 |
| 7 | BaseVar | 124,580,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.79 |
| 9 | EconomicCapitalRatio | 3.55 |